These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6221204)

  • 1. Zimelidine and clomipramine: different influence on fenfluramine but not p-chloroamphetamine-induced pharmacological effects.
    Pawłowski L; Ruczyńska J; Maj J
    Neurosci Lett; 1980 Feb; 16(2):203-7. PubMed ID: 6221204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperthermia induced by amphetamine, p-chloroamphetamine and fenfluramine in the rat-1.
    Frey H-H
    Pharmacology; 1975; 13(2):163-76. PubMed ID: 124876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Test-specific effects of the 5-HT reuptake inhibitors alaproclate and zimelidine on pain sensitivity and morphine analgesia.
    Ogren SO; Holm AC
    J Neural Transm; 1980; 47(4):253-71. PubMed ID: 6446594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different action of 5-hydroxytryptamine (5-HT) uptake inhibitors on fenfluramine- but not p-chloramphetamine-induced hyperthermia in rats.
    Paełowski L
    J Pharm Pharmacol; 1981 Aug; 33(8):538-40. PubMed ID: 6115932
    [No Abstract]   [Full Text] [Related]  

  • 5. Retention deficits induced by acute p-chloroamphetamine following fear conditioning in the rat.
    Archer T; Ogren SO; Ross SB; Magnusson O
    Psychopharmacology (Berl); 1984; 82(1-2):14-9. PubMed ID: 6229804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p-Chloroamphetamine-induced hyperthermia pharmacologically distinct from fenfluramine-induced hyperthermia.
    Quock RM; Weick BG
    J Pharm Pharmacol; 1979 Jan; 31(1):27-32. PubMed ID: 32362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine.
    Colado MI; Murray TK; Green AR
    Br J Pharmacol; 1993 Mar; 108(3):583-9. PubMed ID: 7682129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of serotonin and noradrenaline uptake in human plasma after withdrawal of zimelidine and clomipramine treatment.
    Ross SB; Aberg-Wistedt A
    Psychopharmacology (Berl); 1983; 79(4):298-303. PubMed ID: 6222388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-aggressive effect of zimelidine in isolated mice.
    Ogren SO; Holm AC; Renyi AL; Ross SB
    Acta Pharmacol Toxicol (Copenh); 1980 Jul; 47(1):71-4. PubMed ID: 6446833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Citalopram: a new potent inhibitor of serotonin (5-HT) uptake with central 5-HT-mimetic properties.
    Pawłowski L; Ruczyńska J; Górka Z
    Psychopharmacology (Berl); 1981; 74(2):161-5. PubMed ID: 6267647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of fenfluramine-induced hyperthermia in rats by some, but not all, selective inhibitors of 5-hydroxytryptamine uptake.
    Sugrue MF
    Br J Pharmacol; 1984 Apr; 81(4):651-7. PubMed ID: 6722394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of serotonin uptake blocking agents on the flexor reflex of hind limb of the spinal rat.
    Palider W; Rawlów A
    Pol J Pharmacol Pharm; 1977; 29(4):367-76. PubMed ID: 905204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake of zimelidine and inhibition of uptake of 5-hydroxytryptamine in the isolated, ventilated and perfused rat lung.
    Post C; Hede AR
    Biochem Pharmacol; 1982 Oct; 31(19):3116-9. PubMed ID: 6216892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fenfluramine, p-chloroamphetamine and p-fluoroamphetamine stimulation of pituitary-adrenocortical activity in rat: evidence for differences in site and mechanism of action.
    McElroy JF; Miller JM; Meyer JS
    J Pharmacol Exp Ther; 1984 Mar; 228(3):593-9. PubMed ID: 6323674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alaproclate: further pharmacological evidence for 5-HT uptake inhibition in vivo.
    Rawłów A; Pawłowski L; Przegaliński E
    Arch Int Pharmacodyn Ther; 1983 Oct; 265(2):219-29. PubMed ID: 6651410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine.
    Berger UV; Gu XF; Azmitia EC
    Eur J Pharmacol; 1992 May; 215(2-3):153-60. PubMed ID: 1356787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibition of the cage-leaving response--a model for studies of the serotonergic neurotransmission in the rat.
    Rényi L; Archer T; Minor BG; Tandberg B; Fredriksson A; Ross SB
    J Neural Transm; 1986; 65(3-4):193-210. PubMed ID: 3011984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (MDMA), 4-chloroamphetamine (PCA) and fenfluramine on acoustic and tactile startle reflexes in rats.
    Kehne JH; McCloskey TC; Taylor VL; Black CK; Fadayel GM; Schmidt CJ
    J Pharmacol Exp Ther; 1992 Jan; 260(1):78-89. PubMed ID: 1731054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Test-dependent antinociceptive effect of spinal serotonin release induced by intrathecal p-chloroamphetamine in mice.
    Berge OG; Fasmer OB; Jørgensen HA; Hole K
    Acta Physiol Scand; 1985 Jan; 123(1):35-41. PubMed ID: 3155890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Test-dependent variations in the antinociceptive effect of p-chloroamphetamine-induced release of 5-hydroxytryptamine.
    Ogren SO; Berge OG
    Neuropharmacology; 1984 Aug; 23(8):915-24. PubMed ID: 6237274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.